Axovant Sciences

12 email addresses found for axovant.com
{first}.{l}@axovant.com
12 email addresses
9 sources
http://biospace.com/article/releases/axovant-to-move-stock-exchange-listing-to-nasdaq- October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/axovant-present-key-intepirdine-and-nelotanserin-data-alzheimers October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/fda-grants-fast-track-designation-axovants-nelotanserin-visual October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/new-preclinical-data-intepirdine-suggests-potential September 9, 2017
http://investors.axovant.com/node/7131/html October 10, 2017
http://investors.axovant.com/node/7211/html September 9, 2017
http://life-sciences-germany.com/news/roivant-axovant-negative-ph3-sciences-gmbh-group-nasdaq-2001-111512.html November 11, 2017
http://prnewswire.com/news-releases/axovant-to-move-stock-exchange-listing-to-nasdaq-300507244.html February 2, 2018
http://prnewswire.com/news-releases/english-releases/axovant-announces-negative-topline-results-of-intepirdine-phase-3-mindset-trial-in-alzheimers-disease-300525711.html March 3, 2018
9 sources
http://biospace.com/article/releases/axovant-to-move-stock-exchange-listing-to-nasdaq- October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/axovant-present-key-intepirdine-and-nelotanserin-data-alzheimers October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/fda-grants-fast-track-designation-axovants-nelotanserin-visual October 10, 2017
http://investors.axovant.com/news-releases/news-release-details/new-preclinical-data-intepirdine-suggests-potential September 9, 2017
http://investors.axovant.com/node/7131/html October 10, 2017
http://investors.axovant.com/node/7211/html September 9, 2017
http://life-sciences-germany.com/news/roivant-axovant-negative-ph3-sciences-gmbh-group-nasdaq-2001-111512.html November 11, 2017
http://prnewswire.com/news-releases/axovant-to-move-stock-exchange-listing-to-nasdaq-300507244.html February 2, 2018
http://prnewswire.com/news-releases/english-releases/axovant-announces-negative-topline-results-of-intepirdine-phase-3-mindset-trial-in-alzheimers-disease-300525711.html March 3, 2018
2 sources
http://axovant.com/responsibility/resources-compliance-personnel March 3, 2017
http://investors.axovant.com/node/7041/html March 3, 2018
3 sources
http://investors.axovant.com/investors/press-releases/2016/21-01-2016 April 4, 2016
http://newswire.ca/news-releases/retired-nfl-players-call-for-greater-participation-in-alzheimers-clinical-trials-as-ambassadors-at-educational-events-memory-screenings-in-us-canada-576042441.html May 5, 2017
http://russopartnersllc.com/retired-nfl-players-call-for-greater-participation-in-alzheimers-clinical-trials-as-ambassadors-at-educational-events-memory-screenings-in-u-s-canada August 8, 2016
17 sources
http://alzheimersnewstoday.com/2015/10/07/axovant-screens-first-patients-in-phase-3-mindset-study-on-rvt-101-for-alzheimers-disease August 8, 2017
http://alzheimersweekly.com/2015/11/axovant-developing-2-drugs-3-programs.html November 11, 2016
http://benzinga.com/pressreleases/15/10/n5889669/axovant-sciences-announces-start-of-confirmatory-phase-3-mindset-study- March 3, 2017
http://benzinga.com/pressreleases/15/11/n5956087/axovant-announces-expansion-of-dementia-drug-development-pipeline-and-r March 3, 2017
http://benzinga.com/pressreleases/16/04/n7798980/axovant-sciences-to-present-at-the-goldman-sachs-alzheimers-symposium October 10, 2017
http://benzinga.com/pressreleases/16/08/n8353796/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-f October 10, 2017
http://investors.axovant.com/investors/press-releases/2015/11-04-2015-213056230 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/02-09-2016-211806073 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/02-23-2016-213138995 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/04-04-2016-213134416 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/27-01-2016 April 4, 2016
http://prnewswire.com/news-releases/axovant-sciences-announces-2015-fiscal-year-end-financial-results-and-corporate-updates-300279933.html October 10, 2017
http://prnewswire.com/news-releases/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-financial-results-for-the-first-fiscal-quarter-ended-june-30-2016-300313586.html September 9, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-the-goldman-sachs-alzheimers-symposium-300245720.html October 10, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300172507.html August 8, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300210510.html May 5, 2017
http://satprnews.com/2016/11/07/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-second-fiscal-quarter-and-first-half-ended-september-30-2016 March 3, 2017
17 sources
http://ariva.de/news/axovant-sciences-announces-dementia-pipeline-updates-and-6039321 August 8, 2017
http://axovant.com/clinical-trials/headway-dlb September 9, 2016
http://benzinga.com/pressreleases/16/08/n8353796/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-f October 10, 2017
http://benzinga.com/pressreleases/16/09/n8493973/axovant-sciences-receives-fda-fast-track-designation-for-intepirdine-as July 7, 2017
http://biznewsindex.com/article/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-third-fiscal-quarter-and-nine-months-ended-december-31-2016 February 2, 2017
http://investors.axovant.com/investors/press-releases/2016/02-09-2016-211806073 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/02-23-2016-213138995 April 4, 2016
http://investors.axovant.com/investors/press-releases/2016/06-06-2016 August 8, 2016
http://investors.axovant.com/investors/press-releases/2016/11-07-2016-211717960 December 12, 2016
http://investors.axovant.com/investors/press-releases/2017/02-14-2017-211521196 April 4, 2017
http://medindia.net/health-press-release/axovant-sciences-receives-fda-fast-track-designation-for-intepirdine-as-an-investigational-treatment-for-dementia-with-lewy-bodies-301057-1.htm March 3, 2017
http://prnewswire.com/news-releases/axovant-sciences-announces-2015-fiscal-year-end-financial-results-and-corporate-updates-300279933.html October 10, 2017
http://prnewswire.com/news-releases/axovant-sciences-announces-expansion-of-dementia-pipeline-and-reports-financial-results-for-the-first-fiscal-quarter-ended-june-30-2016-300313586.html September 9, 2017
http://prnewswire.com/news-releases/axovant-sciences-receives-fda-fast-track-designation-for-intepirdine-as-an-investigational-treatment-for-dementia-with-lewy-bodies-300333734.html July 7, 2017
http://prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conference-300224860.html November 11, 2017
http://satprnews.com/2016/11/07/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-second-fiscal-quarter-and-first-half-ended-september-30-2016 March 3, 2017
http://techtrend24.com/axovant-sciences-announces-dementia-pipeline-updates-and-reports-financial-results-for-the-third-fiscal-quarter August 8, 2017
7 sources
http://cnbc.com/2017/11/02/globe-newswire-axovant-announces-second-fiscal-quarter-financial-results-and-corporate-updates.html February 2, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-announces-negative-results-intepirdine-phase-2b-headway June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-licenses-investigational-gene-therapy-parkinsons-disease June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-present-36th-annual-jp-morgan-healthcare-conference June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-present-first-annual-roivant-pipeline-day June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-present-two-upcoming-investor-conferences-0 June 6, 2018
http://traderpower.com/category/news June 6, 2018
7 sources
http://cnbc.com/2017/11/02/globe-newswire-axovant-announces-second-fiscal-quarter-financial-results-and-corporate-updates.html February 2, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-announces-negative-results-intepirdine-phase-2b-headway June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-licenses-investigational-gene-therapy-parkinsons-disease June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-present-36th-annual-jp-morgan-healthcare-conference June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-present-first-annual-roivant-pipeline-day June 6, 2018
http://investors.axovant.com/news-releases/news-release-details/axovant-present-two-upcoming-investor-conferences-0 June 6, 2018
http://traderpower.com/category/news June 6, 2018
1 source
http://axovant.com/responsibility/medical-education November 11, 2017
4 sources
http://axovant.com/about/contact-us/careers March 3, 2017
http://axovant.com/careers October 10, 2017
http://axovant.com/careers/position November 11, 2017
http://axovant.com/contact-us/careers January 1, 2017
Show more results
2 more results for axovant.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about axovant.com

Language of the website: English

Main technologies used:

image/svg+xml

Hunter is the leading solution to find and verify professional email addresses. Search any domain name to find instantly the main email format used in an organization and all the email addresses publicly available on the web.

Discover Hunter

  1. Homepage
  2. Companies directory
  3. A
  4. Axovant Sciences